KEGG: vca:M892_09995
STRING: 338187.VIBHAR_00564
UbiB in Vibrio harveyi is characterized as a probable protein kinase belonging to the ABC1 family, UbiB subfamily. Based on homology with better-characterized bacterial systems, it is predicted to be a multi-pass membrane protein localized to the cell inner membrane . The protein contains conserved domains typical of the ABC1 family of atypical kinases, which are involved in various regulatory processes including ubiquinone biosynthesis. While the exact three-dimensional structure has not been fully determined, it likely shares structural similarities with other ABC1 family members that typically feature kinase-like domains with ATP-binding motifs.
UbiB plays a critical but not fully elucidated role in ubiquinone biosynthesis. It is required, likely indirectly, for the hydroxylation of 2-octaprenylphenol to 2-octaprenyl-6-hydroxy-phenol, which represents a crucial step in the ubiquinone biosynthesis pathway . Unlike other enzymes in this pathway with well-defined catalytic activities, UbiB's precise biochemical mechanism remains somewhat enigmatic. In Escherichia coli, UbiB is involved in both aerobic and anaerobic ubiquinone biosynthesis pathways, suggesting a fundamental role regardless of oxygen conditions . This versatility is significant because it indicates UbiB's potential importance in helping bacteria adapt to various environmental oxygen levels.
For successful expression of recombinant V. harveyi UbiB, specialized expression systems designed for membrane proteins are recommended. Given UbiB's characteristics as a membrane protein, the following methodological approach is advised:
Expression host selection:
E. coli strains C41(DE3) or C43(DE3), which are engineered specifically for membrane protein expression
Alternative hosts like Vibrio species may provide more native-like membrane environments
Vector considerations:
Vectors with tunable promoters (T7 or arabinose-inducible)
Inclusion of appropriate fusion tags (His6, FLAG) for purification
Signal sequences that facilitate proper membrane insertion
Expression conditions:
Lower post-induction temperatures (16-20°C) to slow protein synthesis and promote proper folding
Supplementation with glycerol (5-10%) to stabilize membrane proteins
Controlled induction with reduced inducer concentrations
These strategies aim to balance protein yield with proper folding and membrane insertion, which are critical challenges when working with membrane proteins like UbiB.
Purification of UbiB requires specialized techniques to maintain the protein's native conformation within its membrane environment:
| Purification Stage | Recommended Method | Critical Parameters |
|---|---|---|
| Cell disruption | Sonication or French press | Buffer with protease inhibitors, maintaining 4°C |
| Membrane isolation | Differential ultracentrifugation | 100,000-150,000 × g, 1-2 hours |
| Membrane protein extraction | Detergent solubilization | DDM (0.5-1%), OG (0.5-2%), or digitonin (0.5-1%) |
| Initial purification | IMAC (His-tag) or affinity chromatography | Inclusion of detergent above CMC in all buffers |
| Secondary purification | Size exclusion chromatography | Removal of aggregates, detergent exchange |
| Functional reconstitution | Proteoliposomes or nanodiscs | Lipid composition similar to V. harveyi membranes |
Throughout all purification steps, maintaining detergent concentration above the critical micelle concentration is essential to prevent protein aggregation. For functional studies, reconstitution into lipid bilayers provides a more native-like environment than detergent micelles .
Assessing UbiB enzymatic activity is challenging due to its unclear biochemical function. A multi-faceted approach is recommended:
Kinase activity assays:
ATP binding measurements using isothermal titration calorimetry
ATP hydrolysis detection with coupled enzyme assays
Identification of potential protein or small molecule substrates for phosphorylation
Ubiquinone biosynthesis assays:
In vitro reconstitution of the hydroxylation step (2-octaprenylphenol to 2-octaprenyl-6-hydroxy-phenol)
HPLC or LC-MS analysis of substrate conversion
Complementation with other pathway components to assess UbiB's contribution
Protein-protein interaction studies:
Pull-down assays to identify binding partners
Surface plasmon resonance to quantify interaction kinetics
Cross-linking mass spectrometry to map interaction interfaces
The assessment should include proper controls, including catalytically inactive mutants and related proteins from the UbiB family, to confirm the specificity of observed activities.
Based on research in E. coli, UbiB participates in both aerobic and anaerobic ubiquinone biosynthesis pathways . To distinguish its role under different oxygen conditions in V. harveyi, the following methodological approaches are recommended:
Comparative expression analysis:
qRT-PCR measuring ubiB expression under aerobic, microaerobic, and anaerobic conditions
Western blotting to quantify UbiB protein levels across oxygen conditions
Reporter gene fusions to monitor promoter activity in real-time during oxygen transitions
Functional analysis under controlled oxygen conditions:
UbiB knockout complementation studies under varying oxygen levels
Metabolic labeling with isotope tracers to track ubiquinone synthesis
Oxygen consumption measurements to correlate UbiB function with respiratory activity
Protein complex analysis:
Co-immunoprecipitation under different oxygen conditions to identify oxygen-dependent interaction partners
Blue native PAGE to visualize potential changes in protein complex formation
Comparative crosslinking mass spectrometry across oxygen conditions
| Oxygen Condition | Expected UbiB Interaction Partners | Analytical Method |
|---|---|---|
| Aerobic | UbiA, UbiG, UbiH, UbiE, UbiF | Co-IP, BN-PAGE |
| Anaerobic | UbiA, UbiG, UbiE, UbiT, UbiU, UbiV | Co-IP, BN-PAGE |
| Transitional | Mixture of both aerobic and anaerobic partners | Time-course analysis |
This comparative approach would help delineate how UbiB functions within potentially distinct ubiquinone biosynthesis complexes under different oxygen regimes .
Temperature stress significantly impacts V. harveyi physiology and potentially affects UbiB function and ubiquinone biosynthesis. Research has shown that at elevated temperatures (30°C), V. harveyi undergoes substantial physiological changes, including altered gene expression patterns that affect metabolic pathways . For UbiB specifically, temperature stress likely influences:
Protein stability and activity:
Elevated temperatures may affect UbiB folding and membrane integration
Kinetic parameters of any enzymatic activity may change with temperature
Potential temperature-sensitive protein-protein interactions within the ubiquinone biosynthesis complex
Expression regulation:
Temperature stress response may alter ubiB transcription and translation
Post-translational modifications might be temperature-dependent
Shifts in membrane fluidity at different temperatures could affect UbiB function
Research approaches should include comparative analysis of ubiquinone production at different temperatures in wild-type versus ubiB mutant strains, as well as temperature-dependent protein stability and activity assays .
While direct evidence on UbiB's role in V. harveyi virulence is limited in the provided search results, connections can be drawn based on the fundamental importance of ubiquinone in bacterial metabolism and pathogenicity:
Energy production for virulence mechanisms:
Ubiquinone is essential for aerobic and anaerobic respiration, providing energy for virulence factor production and secretion
V. harveyi adaptation to elevated temperatures (which occurs during infection) shows increased expression of virulence genes despite physiological stress
Disruption of ubiquinone biosynthesis would likely impair energy-dependent virulence mechanisms
Adaptation to host environments:
Stress response integration:
Virulence gene expression in V. harveyi increases under certain stress conditions
UbiB may contribute to coordination between metabolic adaptation and virulence regulation during host colonization
Research approaches would include virulence phenotyping of ubiB mutants in relevant infection models, assessment of virulence factor production, and evaluation of host colonization efficiency .
Comparative analysis of UbiB across bacterial species reveals important evolutionary and functional insights:
Key structural similarities likely include:
Conserved ABC1 kinase domains
Similar membrane topology
Conservation of critical residues involved in ATP binding
Functional conservation analysis suggests UbiB's role in ubiquinone biosynthesis is maintained across these species, but with potential adaptations to different ecological niches and metabolic requirements .
Regulation of ubiB expression appears to be sophisticated and responsive to environmental conditions across bacterial species. Based on research in E. coli, several regulatory mechanisms can be inferred for V. harveyi:
Oxygen-dependent regulation:
Temperature-dependent regulation:
Metabolic integration:
Coordination with central metabolism and respiratory chain components
Potential feedback regulation based on ubiquinone levels or precursor availability
The regulatory architecture likely differs between species based on their specific environmental adaptations, with V. harveyi's regulation potentially optimized for fluctuating marine conditions including temperature, oxygen, and salinity variations .
UbiB represents a potential antimicrobial target due to its essential role in ubiquinone biosynthesis, which is critical for bacterial respiration and energy production. Strategic approaches for targeting UbiB include:
Structure-based inhibitor design:
In silico modeling of UbiB's ATP-binding pocket to design competitive inhibitors
Fragment-based screening to identify molecules that disrupt UbiB function
Allosteric inhibitors targeting unique structural features of bacterial UbiB proteins
Pathway-focused approaches:
Designing mimetics of ubiquinone precursors that block the UbiB-mediated step
Targeting protein-protein interactions between UbiB and other components of the ubiquinone biosynthesis complex
Disrupting the membrane localization of UbiB
Functional screening platforms:
High-throughput assays measuring ubiquinone production in the presence of candidate inhibitors
Growth inhibition assays under conditions requiring functional UbiB
Thermal shift assays to identify compounds that bind and destabilize UbiB
This approach is particularly promising because ubiquinone biosynthesis differs significantly between bacteria and humans, potentially allowing for selective targeting of bacterial UbiB without affecting host metabolism .
Marine environments present dynamic oxygen gradients that require metabolic flexibility. UbiB likely plays a crucial role in V. harveyi's adaptation to these conditions:
Oxygen transition management:
Similar to E. coli, V. harveyi UbiB may function in both aerobic and anaerobic ubiquinone biosynthesis
This dual functionality would allow V. harveyi to maintain respiratory capabilities across varying oxygen conditions in marine environments
UbiB might contribute to the rapid metabolic shifts required when moving between oxygen-rich surface waters and oxygen-limited microenvironments
Integration with stress response mechanisms:
Marine bacteria face multiple simultaneous stressors (temperature, salinity, nutrient limitation)
UbiB's role in maintaining energy production during stress conditions would be critical for survival
Research on V. harveyi adaptation to elevated temperatures (30°C) shows significant physiological adjustments that likely involve respiratory adjustments
Specific adaptations in the V. harveyi UbiB system:
Potential specialization of UbiB function for the marine environment
Possible co-regulation with systems managing other marine stressors
Coordination with V. harveyi's bioluminescence, which requires energy from respiratory metabolism
Understanding this role would provide insights into how V. harveyi maintains energy homeostasis across the diverse microenvironments it encounters in marine ecosystems .
CRISPR-Cas9 technology offers powerful approaches for investigating ubiB function in V. harveyi, but requires optimization for this specific bacterial system:
Delivery system optimization:
Conjugation-based delivery methods may be enhanced when V. harveyi is subjected to mild stress conditions, as research shows stress exposure can trigger improved conjugation efficiency
Electroporation protocols specifically tailored to V. harveyi's cell wall characteristics
Potential use of phage-based delivery systems adapted for Vibrio species
Guide RNA design considerations:
Accounting for V. harveyi genome's GC content and potential off-target sites
Targeting conserved regions of ubiB to ensure complete knockout
Designing guides for precise point mutations to study specific functional domains
Phenotypic analysis strategies:
High-throughput growth assays under various oxygen conditions
Metabolomic profiling to assess changes in ubiquinone and related metabolites
Complementation with wild-type and mutant versions to confirm phenotype specificity
For precise genetic manipulation, researchers should consider that V. harveyi shows enhanced capacity to receive plasmids when treated with specific stress conditions, such as brief exposure to 0.04–0.05 M NaOH for 5–20 minutes or 0.012-0.024 M HCl for 5–30 minutes .
Based on research in E. coli, UbiB functions alongside the UbiUVT complex in anaerobic ubiquinone biosynthesis . Investigating these interactions in V. harveyi would require sophisticated experimental approaches:
Protein interaction mapping:
Bacterial two-hybrid or split-protein complementation assays to detect direct interactions
Co-immunoprecipitation followed by mass spectrometry to identify interaction partners
Crosslinking mass spectrometry to map interaction interfaces at amino acid resolution
Structural biology approaches:
Cryo-electron microscopy of the entire ubiquinone biosynthesis complex
X-ray crystallography of co-purified components
Hydrogen-deuterium exchange mass spectrometry to identify regions involved in protein-protein interactions
Functional reconstitution experiments:
In vitro reconstitution of the complete biosynthetic pathway with purified components
Activity assays with systematic omission of individual components
Mutational analysis of predicted interaction interfaces
This multi-faceted approach would help determine whether V. harveyi utilizes a similar UbiUVT system for anaerobic ubiquinone biosynthesis as observed in E. coli, and how UbiB integrates with this complex .